Head Topics

AstraZeneca gets FDA OK for gastric cancer drug

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 97%

United States Headlines News

United States Latest News,United States Headlines

AstraZeneca PLC said Monday that the U.S. Food and Drugs Administration has approved Enhertu as a treatment for patients with gastric cancer. The pharmaceutical giant has developed Enhertu --a HER2-directed antibody drug conjugate-- in collaboration with Japan's Sankyo Company Ltd. AstraZeneca will pay $115 million to Sankyo as a combined second and third milestone payment for reaching the goal of approval in the U.S.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.